Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email email@example.com.
Check back regularly for news, coverage, and announcements about MAVA.
San Mateo, California-based BlockCypher, a block chain web services startup, has secured over $3.1 million in seed funding.
San Diego-based Obalon Therapeutics, a developer of gastric balloon technology for weight loss therapy, has received $20 million in Series D funding and a $10 million loan from Square 1 Bank.
New Enterprise Associates (NEA), one of the largest venture capital firms around, is raising its 15th fund.
Cortendo AB has agreed to receive up to $27.5 million in a private placement.
Sensory NeuroStimulation, Inc., makers of the Relaxis™ device for treating Restless Legs Syndrome (RLS), has entered into a new credit agreement with Silicon Valley Bank, the company announced today.
Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting, has entered into a loan and security agreement with Hercules Technology Growth Capital, Inc. for a term loan of up to $26.0 million and completed a private placement for $1.0 million of Cerulean common stock with Hercules.
Trevi Therapeutics, Inc., a late-stage clinical development company focused on developing Nalbuphine ER for chronic pruritus conditions, announced the closing of a $15 million senior secured term loan agreement provided by Solar Capital Ltd. as collateral agent and lender and Square 1 Bank as lender.
Welltok, developer of the CafeWell Health Optimization Platform, officially closed its most recent funding round of $37 million.
Trevi Therapeutics has secured a $15 million senior loan from Solar Capital and Square 1 Bank.
Surface Oncology has secured $35 million in Series A funding.